Showing results (751-760 of 3,591) with videos related to
Sort By:
Pageof 360
Journal of Viral Hepatitis|November 11, 2021
A cluster randomized controlled trial of a MedicineInsight Educational Quality Improvement Programme to improve the diagnosis and treatment of chronic hepatitis C in general practice (the EQUIP-HEPC trial)Kendal Chidwick, Rimma Myton, Anthony Rodgers, et al.Journal of Viral Hepatitis|January 10, 2014
Sequences in the terminal protein and reverse transcriptase domains of the hepatitis B virus polymerase contribute to RNA binding and encapsidationF Cao, S Jones, W Li, et al.Journal of Viral Hepatitis|January 4, 2014
Suppressive activity and altered conventional phenotype markers/mediators of regulatory T cells in patients with self-limiting hepatitis ES B Rathod, R Das, S Thanapati, et al.Journal of Viral Hepatitis|May 20, 2014
Human microRNA hsa-miR-1231 suppresses hepatitis B virus replication by targeting core mRNAT Kohno, M Tsuge, E Murakami, et al.Journal of Viral Hepatitis|June 4, 2014
Decline in intrahepatic cccDNA and increase in immune cell reactivity after 12 weeks of antiviral treatment were associated with HBeAg lossQ Zheng, Y Y Zhu, J Chen, et al.Journal of Viral Hepatitis|January 27, 2015
Association of an HLA-G 14-bp Insertion/Deletion polymorphism with high HBV replication in chronic hepatitisA B Laaribi, I Zidi, N Hannachi, et al.Journal of Viral Hepatitis|August 7, 2012
Impact of hepatitis C on survival in dialysis patients: a link with cardiovascular mortality?F Fabrizi, V Dixit, P MessaJournal of Viral Hepatitis|August 7, 2012
Concentration-guided ribavirin dosing with darbepoetin support and peg-IFN alfa-2a for treatment of hepatitis C recurrence after liver transplantationM Ackefors, H Gjertsen, A Wernerson, et al.Journal of Viral Hepatitis|August 7, 2012
Peginterferon-Α_2B plus ribavirin is more effective than peginterferon-Α_2A plus ribavirin in menopausal women with chronic hepatitis CE Villa, C Cammà, A Di Leo, et al.Journal of Viral Hepatitis|August 7, 2012
Interleukin-28B (IL-28B) single-nucleotide polymorphisms and interferon plus ribavirin treatment outcome in Italian chronically HCV-infected patientsE Riva, C Scagnolari, K Monteleone, et al.Pageof 360